Corrections

Management of hypertension: summary of NICE guidance

BMJ 2011; 343 doi: https://doi.org/10.1136/bmj.d6255 (Published 29 September 2011) Cite this as: BMJ 2011;343:d6255

In a rapid response to this Practice article by Taryn Krause and colleagues (BMJ 2010;343:d4891 doi:10.1136/bmj.d4891), Kate Harding and colleagues write that it “does not mention that women of child bearing potential should not be treated with either ACE inhibitors or ARBs without a detailed discussion of the teratogenic potential of these drugs, and advice to discontinue them preferably prior to conception” (www.bmj.com/content/343/bmj.d4891.extract/reply#bmj_el_269620). In reply, the authors acknowledge the omission from this summary document but point out that the full NICE guidance does contain specific recommendations on the subject (www.bmj.com/content/343/bmj.d4891.extract/reply#bmj_el_270204).

Notes

Cite this as: BMJ 2011;343:d6255

View Abstract